trending Market Intelligence /marketintelligence/en/news-insights/trending/_S5QlawEkmDbrA7lNRXzog2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Phosphagenics to sell BioElixia brand

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Phosphagenics to sell BioElixia brand

Phosphagenics Ltd. agreed to sell its global BioElixia beauty brand to Pure Beauty Australia Pty Ltd., a unit of private investment group CEM Group of Companies.

The deal will allow Pure Beauty to market and expand the BioElixia range, which comprises products that contain Phosphagenics' proprietary drug delivery system called targeted penetration matrix, or TPM. The sale is in line with Phosphagenics' strategic decision to focus on core TPM businesses.

Phosphagenics will receive a A$200,000 up-front payment, ongoing royalties of 5% based on net sales of products containing TPM and payments from an associated 10-year TPM supply agreement.

The transaction is expected to close the week of Aug. 14.

As of Aug. 9, US$1 was equivalent to A$1.27.